Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare & Medicaid Services (CMS) for the opportunity to provide comments in response to the “Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program” (Proposed Rule), issued on July 16, 2025.
Susan Cantrell, RPh, MHL, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP), warns that politicizing the Advisory Committee on Immunization Practices (ACIP) could undermine vaccine trust.
On September 9, 2025, the Make America Healthy Again Commission (MAHA Commission) issued a strategy report titled, Make our Children Health Again (MOCHA Strategy Report).
On September 9, 2025, the Make America Healthy Again (MAHA) Commission released the “Make Our Children Healthy Again (MOCHA) Strategy,” which follows an earlier report that assessed key drivers of childhood chronic disease, including poor diet, chemical exposure, lack of physical activity and chronic stress, and overmedicalization. Executive Order 14212, signed by President Trump on February 13, tasks the commission with providing government-wide recommendations on policy and strategy to address the identified contributing causes and end the childhood chronic disease crisis.
On August 28, Chairman Crapo announced that Secretary Kennedy would testify before the Senate Finance Committee to preview the Trump administration’s 2026 health care agenda, including the Make America Healthy Again (MAHA) initiative.
With the end of August recess, Members of Congress returned to Washington D.C. this week to tackle government funding and the remaining policy priorities not included in the One Big Beautiful reconciliation Bill (H.R. 1).
Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - September 2025 Issue
August 2025 Legislative Briefing
